Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
33 Leser
Artikel bewerten:
(0)

Neurovascular Devices/Interventional Neurology Market Worth $2,370.4 Million by 2020

PUNE, India, October 7, 2015 /PRNewswire/ --

According to a new market research report "Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product (Carotid Stent, Flow Diversion, Microcatheter, Clot Retrieval, Suction Device) - Global Forecast to 2020", published by MarketsandMarkets, the global Neurovascular Devices/Interventional Neurology Market Is poised to reach $2,370.4 Million by 2020, growing at a CAGR of 8.4% from 2015 to 2020.


Browse 91 market data Tables and 46 Figures spread through 175 Pages and in-depth TOC on "Neurovascular Devices/Interventional Neurology Market"

http://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulation-devices-market-847.html

Early buyers will receive 10% customization on this report.

On the basis of products, the global Neurovascular Devices/Interventional Neurology Market is classified into four major segments, namely, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. On the basis of technology, the global Neurovascular Devices/Interventional Neurology Market is classified into embolization & coiling, carotid artery angioplasty & stenting, supporting techniques, and neurothrombectomy.

Factors such as growth in the target patient population, technological advancement in the field of interventional neurosurgeries, favorable medical reimbursements across mature markets, and expanding healthcare infrastructure across developing countries are driving the growth of the Neurovascular Devices/Interventional Neurology Market during the forecast period. On the other hand, ongoing healthcare reforms in the U.S. and a dearth of skilled neurosurgeons are restraining the growth of this market.

In 2015, North America is expected to hold the largest share of the Neurovascular Devices/Interventional Neurology Market, followed by Europe. Additionally, Asia-Pacific is expected to grow at the highest CAGR during the forecast period (2015 to 2020). Strong market growth witnessed in the North American Neurovascular Devices/Interventional Neurology Market can be attributed to factors such as significant adoption of neurovascular devices among neurosurgeons, favorable reimbursement scenario, and strong presence of device manufacturers in the region.

Download Free Sample Pages: http://www.marketsandmarkets.com/pdfdownload.asp?id=847

Stryker Corporation (U.S.), Medtronic, plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), Microport Scientific Corporation (China), and Medikit Co., Ltd. (Japan) are the key players operating in the global Neurovascular Devices/Interventional Neurology Market.

Browse Related Reports:

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson's, Tinnitus, Alzheimer's, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020.

http://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html

Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019.

http://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

About MarketsandMarkets:

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune - 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/medical-devices

Connect with us on LinkedIn@http://www.linkedin.com/company/marketsandmarkets


KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.